Cognitive functions in myoclonic epilepsy with ragged red fibres – a case report

Ardila A.:A Neuropsychological Approach to Intelligence. Neuropsychology Review, 1999, 9: 117–136.10.1023/A:1021674303922Search in Google Scholar

Bosbach S., Kornblum C., Schroder R., Wagner M.:Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns–Sayre syndrome. Brain, 2003, 126: 1231–1240.10.1093/brain/awg101Search in Google Scholar

Finsterer J.:Cognitive decline as a manifestation of mitochondrial disorders(mitochondrial dementia). Journal of the Neurological Sciences, 2008, 272: 20–33.10.1016/j.jns.2008.05.011Search in Google Scholar

Finsterer J.:Mitochondrial disorders, cognitive impairment and dementia. Journal of the Neurological Sciences, 2009, 283: 143–148.10.1016/j.jns.2009.02.347Search in Google Scholar

Gillham R.A., Read C.L., McKee P.J.W., Larkin J.G., Brodie M.J.:Cognitive function in adult epileptic patients on long-term sodium valproate. Journal of Epilepsy, 1991, 4: 205–210.10.1016/0896-6974(91)90077-VSearch in Google Scholar

Hirano M., DiMauro S.:Clinical features of mitochondrial myopathies and encephalomyopathies. Gene Revievs, 2015.Search in Google Scholar

Kartsounis L.D.,Troung D.D., Morgan-Hughes J.A., Hearding A.E.:The neuropsychological features of mitochondrial myophaties and encepalomyopathies. Archives of Neurology, 1992, 49: 158–160.10.1001/archneur.1992.005302600580201736848Search in Google Scholar

Kaufmann P., Shungu D.C., Sano M.C., Jhung S., Engelstad K., Mitsis E. et al.:Cerebral lactic acidosis correlates with neurological impairement in MELAS. Neurology, 2004, 62: 1297–1302.10.1212/01.WNL.0000120557.83907.A815111665Search in Google Scholar

Koo D.L., Hwang K.J., Kim D., Kim Y.J., Kim J.Y., Shin W. et al.:Effects of Levetiracetam Monotherapy on the Cognitive Function of Epilepsy Patients. Eur. Neurol., 2013, 70: 88–94.10.1159/00034723023839084Search in Google Scholar

Lang C.J., Brenner P., Heussa D., Engelhardt A., Reichmann H., Seibel P. et al.:Neuropsychological status of mitochondrial encephalomyopathies. European Journal of Neurology, 1995, 2: 171–176.10.1111/j.1468-1331.1995.tb00112.x24283633Search in Google Scholar

Lezak M.D.:IQ: RIP. Journal of Clinical and Experimental Neuropsychology, 1988, 10: 351–361.10.1080/016886388084008713292568Search in Google Scholar

Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen et al.:Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine, 2009, 360: 1597–1605.10.1056/NEJMoa0803531Search in Google Scholar

Patat A., Klein M.J., Surjus A., Rostand A., Granier J.:Study of Effects of Clobazam and Lorazepam on Memory and Cognitive Functions in Healthy Subjects. Human Psychopharmacology: Clinical & Experimental, 1991, 3: 229–241.Search in Google Scholar

Sartor H., Loose R., Tucha O., Klein H.E., Lange K.W.:MELAS: a neuropsychological and radiological follow-up study. Acta Neurologica Scandinavica, 2002, 106: 309–313.10.1034/j.1600-0404.2002.01089.xSearch in Google Scholar

Turconi A.C., Benti R., Castelli E., Pohintesta S., Felisari G., Comi G. et al.:Focal Cognitive impairement in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. Journal of Neurological Sciences, 1999, 170: 57–63.10.1016/S0022-510X(99)00199-9Search in Google Scholar

Wheless J.W., Phelps S.J.:Clobazam: A newly approved but well-established drug for the treatment of intractable epilepsy syndromes. Journal of Child Neurology, 2013, 28: 219–229.10.1177/088307381246360923112237Search in Google Scholar

Zeviani M., Carelli V.:Mitochondrial disorders. Current Opinion in Neurology, 2007, 20: 564–571.10.1097/WCO.0b013e3282ef58cd17885446Search in Google Scholar